Skip to main content
Erschienen in: Urolithiasis 5/2012

01.10.2012 | Original Paper

Hypercalciuria, hyperoxaluria, and hypocitraturia screening from random urine samples in patients with calcium lithiasis

verfasst von: Miguel Angel Arrabal-Polo, Salvador Arias-Santiago, María Sierra Girón-Prieto, Felix Abad-Menor, Fernando López-Carmona Pintado, Armando Zuluaga-Gomez, Miguel Arrabal-Martin

Erschienen in: Urolithiasis | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Calcium lithiasis is the most frequently diagnosed renal lithiasis and is associated with a high percentage of patients with metabolic disorders, such as hypercalciuria, hypocitraturia, and hyperoxaluria. The present study included 50 patients with recurrent calcium lithiasis. We conducted a random urine test during nocturnal fasting and a 24-h urine test, and examined calcium, oxalate, and citrate. A study of the linear correlation between the metabolites was performed, and the receiver operator characteristic (ROC) curves were analyzed in the random urine samples to determine the cutoff values for hypercalciuria (excretion greater than 200 mg), hyperoxaluria (excretion greater than 40 mg), and hypocitraturia (excretion less than 320 mg) in the 24-h urine. Linear relationships were observed between the calcium levels in the random and 24-h urine samples (R = 0.717, p = 0.0001), the oxalate levels in the random and 24-h urine samples (R = 0.838, p = 0.0001), and the citrate levels in the random and 24-h urine samples (R = 0.799, p = 0.0001). After obtaining the ROC curves, we observed that more than 10.15 mg/dl of random calcium and more than 16.45 mg/l of random oxalate were indicative of hypercalciuria and hyperoxaluria, respectively, in the 24-h urine. In addition, we found that the presence of less than 183 mg/l of random citrate was indicative of the presence of hypocitraturia in the 24-h urine. Using the proposed values, screening for hypercalciuria, hyperoxaluria, and hypocitraturia can be performed with a random urine sample during fasting with an overall sensitivity greater than 86 %.
Literatur
1.
Zurück zum Zitat Chandhoke PS (2007) Evaluation of the recurrent stone former. Urol Clin North Am 34(3):315–322PubMedCrossRef Chandhoke PS (2007) Evaluation of the recurrent stone former. Urol Clin North Am 34(3):315–322PubMedCrossRef
2.
Zurück zum Zitat Park S, Pearle MS (2007) Pathophysiology and management of calcium stones. Urol Clin North Am 34:323–334PubMedCrossRef Park S, Pearle MS (2007) Pathophysiology and management of calcium stones. Urol Clin North Am 34:323–334PubMedCrossRef
3.
Zurück zum Zitat Pak CYC, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115:26–32PubMedCrossRef Pak CYC, Poindexter JR, Adams-Huet B, Pearle MS (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115:26–32PubMedCrossRef
4.
Zurück zum Zitat Ossandón Salas E, Storme Cabrera O, Ledesma R, Marchant González F, Palma Ceppi C, Recabal Guiraldes P (2009) Metabolic study results of 54 patients with high risk of recurrent urolithiasis. Actas Urol Esp 33:429–432PubMedCrossRef Ossandón Salas E, Storme Cabrera O, Ledesma R, Marchant González F, Palma Ceppi C, Recabal Guiraldes P (2009) Metabolic study results of 54 patients with high risk of recurrent urolithiasis. Actas Urol Esp 33:429–432PubMedCrossRef
5.
Zurück zum Zitat Netelenbos JC, Zwijnenburg PJ, ter Wee PM (2005) Risk factors determining active urinary stone formation in patients with urolithiasis. Clin Nephrol 63:188–192PubMed Netelenbos JC, Zwijnenburg PJ, ter Wee PM (2005) Risk factors determining active urinary stone formation in patients with urolithiasis. Clin Nephrol 63:188–192PubMed
6.
Zurück zum Zitat Krepinsky J, Ingram AJ, Churchill DN (2000) Metabolic investigation of recurrent nephrolithiasis: compliance with recommendations. Urology 20:915–920CrossRef Krepinsky J, Ingram AJ, Churchill DN (2000) Metabolic investigation of recurrent nephrolithiasis: compliance with recommendations. Urology 20:915–920CrossRef
7.
Zurück zum Zitat Ferraz RR, Baxmann AC, Ferreira LG, Nishiura JL, Siliano PR, Gomes SA et al (2006) Preservation of urine samples for metabolic evaluation of stone-forming patients. Urol Res 34:329–337PubMedCrossRef Ferraz RR, Baxmann AC, Ferreira LG, Nishiura JL, Siliano PR, Gomes SA et al (2006) Preservation of urine samples for metabolic evaluation of stone-forming patients. Urol Res 34:329–337PubMedCrossRef
8.
Zurück zum Zitat Lewandowski S, Rodgers AL (2004) Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 345:17–34PubMedCrossRef Lewandowski S, Rodgers AL (2004) Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 345:17–34PubMedCrossRef
9.
Zurück zum Zitat Strohmaier WL, Hoelz KJ, Bichler KH (1997) Spot urine samples for the metabolic evaluations of urolithiasis patients. Eur Urol 32:294–300PubMed Strohmaier WL, Hoelz KJ, Bichler KH (1997) Spot urine samples for the metabolic evaluations of urolithiasis patients. Eur Urol 32:294–300PubMed
10.
Zurück zum Zitat Coe FL, Evan A, Worcester E (2011) Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6:2083–2092PubMedCrossRef Coe FL, Evan A, Worcester E (2011) Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6:2083–2092PubMedCrossRef
12.
Zurück zum Zitat Chandhoke PS (2001) Economics of urolithiasis: cost-effectiveness of therapies. Curr Opin Urol 11:391–393PubMedCrossRef Chandhoke PS (2001) Economics of urolithiasis: cost-effectiveness of therapies. Curr Opin Urol 11:391–393PubMedCrossRef
13.
14.
15.
Zurück zum Zitat Lotan Y, Cadeddu JA, Pearle MS (2005) International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res 33:223–230PubMedCrossRef Lotan Y, Cadeddu JA, Pearle MS (2005) International comparison of cost effectiveness of medical management strategies for nephrolithiasis. Urol Res 33:223–230PubMedCrossRef
16.
Zurück zum Zitat Amaro CR, Goldberg J, Amaro JL, Padovani CR (2005) Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 31:29–33PubMedCrossRef Amaro CR, Goldberg J, Amaro JL, Padovani CR (2005) Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 31:29–33PubMedCrossRef
17.
Zurück zum Zitat Krautschick AW (1999) Metabolic evaluation and medical therapy for stone formation. Curr Opin Urol 9:335–338PubMedCrossRef Krautschick AW (1999) Metabolic evaluation and medical therapy for stone formation. Curr Opin Urol 9:335–338PubMedCrossRef
18.
Zurück zum Zitat Arrabal-Polo MA, Arrabal-Martin M, de Haro-Muñoz T, Poyatos-Andujar A, Palao-Yago F, Zuluaga-Gomez A (2012) Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis. Urology 79:48–54PubMedCrossRef Arrabal-Polo MA, Arrabal-Martin M, de Haro-Muñoz T, Poyatos-Andujar A, Palao-Yago F, Zuluaga-Gomez A (2012) Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis. Urology 79:48–54PubMedCrossRef
19.
Zurück zum Zitat Capolongo G, Sakhaee K, Pak CY, Maalouf NM (2011) Fasting versus 24-h urine pH in the evaluation of nephrolithiasis. Urol Res 39(5):367–372PubMedCrossRef Capolongo G, Sakhaee K, Pak CY, Maalouf NM (2011) Fasting versus 24-h urine pH in the evaluation of nephrolithiasis. Urol Res 39(5):367–372PubMedCrossRef
20.
Zurück zum Zitat Hong YH, Dublin N, Razack AH, Mohd MA, Husain R (2010) Twenty-four hour and spot urine metabolic evaluations: correlations versus agreements. Urology 75:1294–1298PubMedCrossRef Hong YH, Dublin N, Razack AH, Mohd MA, Husain R (2010) Twenty-four hour and spot urine metabolic evaluations: correlations versus agreements. Urology 75:1294–1298PubMedCrossRef
21.
Zurück zum Zitat Worcester EM, Coe FL (2008) New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28:120–132PubMedCrossRef Worcester EM, Coe FL (2008) New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28:120–132PubMedCrossRef
22.
Zurück zum Zitat Trincheri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162:27–30CrossRef Trincheri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162:27–30CrossRef
23.
Zurück zum Zitat Arrabal Martín M, Fernández Rodríguez A, Arrabal Polo MA, Ruiz García MJ, Zuluaga Gómez A (2006) Study of the physical-chemical factors in patients with renal lithiasis. Arch Esp Urol 59:583–594PubMed Arrabal Martín M, Fernández Rodríguez A, Arrabal Polo MA, Ruiz García MJ, Zuluaga Gómez A (2006) Study of the physical-chemical factors in patients with renal lithiasis. Arch Esp Urol 59:583–594PubMed
24.
Zurück zum Zitat Karabacak OR, Ipek B, Ozturk U, Demirel F, Saltas H, Altug U (2010) Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease. Urology 76:238–241PubMedCrossRef Karabacak OR, Ipek B, Ozturk U, Demirel F, Saltas H, Altug U (2010) Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease. Urology 76:238–241PubMedCrossRef
25.
Zurück zum Zitat Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M (2000) A study of the etiology of idiopathic calcium urolithiasis in children: hypocitraturia is the most important risk factor. J Urol 164:162–165PubMedCrossRef Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M (2000) A study of the etiology of idiopathic calcium urolithiasis in children: hypocitraturia is the most important risk factor. J Urol 164:162–165PubMedCrossRef
26.
Zurück zum Zitat Simic-Ogrizovic S, Dopsaj V, Jovicic S, Milenkovic D, Jovanovic D, Nesic V (2007) The most important factor for active urinary stone formation in patients with urolithiasis. Med Pregl 60:117–120PubMed Simic-Ogrizovic S, Dopsaj V, Jovicic S, Milenkovic D, Jovanovic D, Nesic V (2007) The most important factor for active urinary stone formation in patients with urolithiasis. Med Pregl 60:117–120PubMed
Metadaten
Titel
Hypercalciuria, hyperoxaluria, and hypocitraturia screening from random urine samples in patients with calcium lithiasis
verfasst von
Miguel Angel Arrabal-Polo
Salvador Arias-Santiago
María Sierra Girón-Prieto
Felix Abad-Menor
Fernando López-Carmona Pintado
Armando Zuluaga-Gomez
Miguel Arrabal-Martin
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 5/2012
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-012-0474-2

Weitere Artikel der Ausgabe 5/2012

Urolithiasis 5/2012 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.